[Allogenic stem cell transplantations in lymphoma patients]. / Lymfoomapotilaiden allogeeniset kantasolujensiirrot.
Duodecim
; 126(2): 167-73, 2010.
Article
em Fi
| MEDLINE
| ID: mdl-20405602
ABSTRACT
The disease recurs in a significant proportion of lymphoma patients after the first-line treatment. Intensive treatment supported by the patient's own cells (autologic stem cell transplantation) has long been utilized in selected cases, but restrictions of this form of therapy are well known. Allogenic transplantation with another person's stem cells provides a possibility to treat lymphoma having a poor prognosis even in cases where other methods of treatments have failed. Allogeneic stem cell transplantation is, however, associated with a significant risk of death.
Buscar no Google
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Transplante de Células-Tronco Hematopoéticas
/
Linfoma
Tipo de estudo:
Prognostic_studies
Limite:
Humans
Idioma:
Fi
Revista:
Duodecim
Ano de publicação:
2010
Tipo de documento:
Article